SQ-17

N/A

Report date: 2024/01/03 09:48:08
NME

Base Information

Drug NameSQ-17
Drug Alias NameSQ-17
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain-containing protein 4 inhibitors
TargetsBromodomain-containing protein 4
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCollege of Pharmaceutical Sciences Zhejiang University
China Registration ClassN/A

Develop Information

Active CompaniesCollege of Pharmaceutical Sciences Zhejiang University
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A